CLRS Stock Overview
Engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Clariant AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 11.30 |
| 52 Week High | CHF 15.30 |
| 52 Week Low | CHF 10.80 |
| Beta | 0.72 |
| 11 Month Change | -10.32% |
| 3 Month Change | -15.04% |
| 1 Year Change | -13.08% |
| 33 Year Change | -34.30% |
| 5 Year Change | -36.49% |
| Change since IPO | -31.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLRS | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -8.9% | -0.6% | 0.2% |
| 1Y | -13.1% | -0.3% | 8.5% |
Return vs Industry: CLRS underperformed the German Chemicals industry which returned -0.3% over the past year.
Return vs Market: CLRS underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| CLRS volatility | |
|---|---|
| CLRS Average Weekly Movement | 6.9% |
| Chemicals Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: CLRS's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: CLRS's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1886 | 10,568 | Conrad Keijzer | www.clariant.com |
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide. The Care Chemicals segment offers specialty chemicals and application solutions for various applications in automotive fluids, aviation, construction chemicals, crop solutions, health care, home care, industrial lubricants, paints and coatings, personal care, and special solvents. The Catalysis segment provides catalyst products for use as ammonia cracking, ammonia, custom catalysts, ethylene and derivatives, fischer-tropsch, fuel cell, fuel upgrading, gas processing, hydrogen, hydrogenation, liquid hydrogen carrier, low-carbon ammonia, low-carbon methanol, methanol, methanol-to-propylene, off-gas treatment, olefins purification, on-purpose propylene, oxidation, polypropylene, refinery stream purification, styrene, zeolite powders, biocatalysis, cellulosic ethanol, cellulosic sugars, low-carbon advanced biofuels, and residue-derived biochemical intermediates.
Clariant AG Fundamentals Summary
| CLRS fundamental statistics | |
|---|---|
| Market cap | €3.86b |
| Earnings (TTM) | €126.72m |
| Revenue (TTM) | €4.47b |
30.4x
P/E Ratio0.9x
P/S RatioIs CLRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLRS income statement (TTM) | |
|---|---|
| Revenue | CHF 4.16b |
| Cost of Revenue | CHF 2.94b |
| Gross Profit | CHF 1.22b |
| Other Expenses | CHF 1.10b |
| Earnings | CHF 118.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 28, 2025
| Earnings per share (EPS) | 0.36 |
| Gross Margin | 29.28% |
| Net Profit Margin | 2.83% |
| Debt/Equity Ratio | 78.3% |
How did CLRS perform over the long term?
See historical performance and comparison